CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

Issuer: CureVac


/ Key word: Study





CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK...

Related Keywords

Netherlands ,Belgium ,Germany ,Switzerland ,United States ,Sarah Fakih ,Myriam Mendila ,Patrick Perez ,Corporate Communications ,Development In Collaboration ,World Health Organization ,Junior ,Curevac Announces Dosing ,First Participant ,Seasonal Influenza ,Chief Scientific Officer ,Junior Manager Public ,Vice President Corporate Communications ,